Results 11 to 20 of about 44,008 (229)

Diabetic macular edema

Nepalese Journal of Ophthalmology, 2016
Diabetic retinopathy is a frequent manifestation of long standing diabetes mellitus. According to the World Health Organization diabetes affects nine percent of the adult population worldwide (Diabetes Fact Sheet, 2015). Of all of the common diseases of the eye, diabetic retinopathy has a great impact on the working age population and therefore ...
Steven J, Marks, Benjamin P, Hale
  +10 more sources

Diabetic macular edema

Saudi Journal of Ophthalmology, 2009
A variety of treatment options are available for the treatment of diabetic macular edema. They include laser photocoagulation, anti-VEGF drugs, intravitreal steroids, and vitrectomy with or without release of vitreoretinal traction. A full understanding of the physiological mechanisms of these treatment modalities allows sensible combination of ...
Ritesh Narula, Manisha Agarwal, S.P. Chaudhary, Cyrus Shroff   +3 more
  +5 more sources

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX‑EMD Study [PDF]

, 2020
Background The clinical and economic management of retinal diseases has become more complex following the introduction of new intravitreal treatments. Multicriteria decision analysis (MCDA) offers the potential to overcome the challenges associated with ...
Casado, Miguel Ángel, Cervera, Enrique, de Andrés‑Nogales, Fernando, García Layana, Alfredo, Ignacio García, Emilio Francisco, Llorente, Iñaki, Martínez Olmos, José, Martínez Sesmero, José Manuel, Martínez, Mercedes, Mur, Carlos, Ortiz, Pere, Peralta, Gemma, Poveda, José Luis, Rodríguez Maqueda, Mariano, Ruiz Moreno, José María, Trillo, José Luis, Udaondo, Patricia, Zarranz Ventura, Javier, Zulueta, Jacinto, Álvarez, Eloísa   +19 more
core   +3 more sources

Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone.

PLoS ONE, 2017
PurposeTo examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema.Materials and methodsIn this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any ...
Eva K Fenwick, Jing Xie, Ryan E K Man, Charumathi Sabanayagam, Lyndell Lim, Gwyn Rees, Tien Y Wong, Ecosse L Lamoureux   +7 more
doaj   +1 more source

Optical coherence tomography fast versus regular macular thickness mapping in diabetic retinopathy [PDF]

, 2008
Objective: The purpose of the study was to investigate if absolute values and reproducibility of thickness maps obtained from 2 optical coherence tomography (OCT) scanning protocols, regular high-resolution and fast low-density mode, differ in patients ...
Ceklic, Lala, Maar, Noemi, Neubauer, Aljoscha Steffen   +2 more
core   +1 more source

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]

, 2016
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo, CARLESIMO, Sandra Cinzia, Forastiere, Michele, NEBBIOSO, Marcella, PACELLA, Elena, PACELLA, FERNANDA, SECONDI, ROBERTO   +6 more
core   +1 more source

Laser treatment in diabetic retinopathy [PDF]

, 2007
Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries due to macular edema and proliferative diabetic retinopathy (PDR). For both complications laser treatment may offer proven therapy: the Diabetic Retinopathy
Akduman L, Aljoscha S. Neubauer, Arend O, Bandello F, Benson WE, Chew EY, Davies N, Ferris, Ferris F, Friberg TR, Gabel VP, Gallemore RP, Giovannini A, Gupta V, Hainsworth DP, Jaffe GJ, Kinyoun J, Klein R, Kroll P, Ladas ID, Laursen ML, Lee CM, Lewis H, Luttrull JK, Maeshima K, Michael W. Ulbig, Neubauer AS, Parolini B, Puliafito CA, Sanchez-Tocino H, Schatz H, Shahidi M, Shimura M, Ulbig MR, Ulbig MW, Ulbig MW, Xu X   +36 more
core   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T., Bonfiglio V., Fallico M., Fichera S., Longo A., Macchi I., Pizzo A., Rapisarda C., Reibaldi M., Russo A.   +9 more
core   +2 more sources

Idiopathic thrombocytopenic purpura and its fundus features in a patient with diabetes mellitus

Indian Journal of Ophthalmology, 2020
In this case report, we present a patient with thrombocytopenia secondary to idiopathic thrombocytopenic purpura (ITP), whose fundus appearance had features of diabetic retinopathy with macular edema.
R Rajesh, Mahesh P Shanmugam, Pradeep Sagar   +2 more
doaj   +1 more source

Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography [PDF]

Egyptian Journal of Medical Research, 2022
Background: Diabetic macular edema (DME) can occur at any stage of non-proliferative and proliferative diabetic retinopathy. It is characterized by a swelling of the macular area that normally accounts for high-resolution visual acuity (VA), and DME ...
Hossam El din Khalil, Abdel Rahman Ahmed, Hassan Mahfouz Eliwa   +2 more
doaj   +1 more source